Predict your next investment

Orionis Biosciences company logo
HEALTHCARE | Stealth Mode
orionisbio.com

See what CB Insights has to offer

Executives

1

Board of Directors

2

Orionis Biosciences Board of Directors

2 Board of directors

Orionis Biosciences has 2 board of directors, including Matias Tezanos.

Name

Firm

Work History

Other Seats

Matias Tezanos

22 years building tech companies. Investor in global ventures, most based in the US. A few in Latin America. A few in Europe. A few in Asia. 4 exits as CEO during a 14 year window (one at a time). The exits enabled me to start investing in innovative founders/teams/companies, which turned out to be an activity I really enjoy doing.

Advano, Diamond Foundry, Getaround, and Kaptyn

Willem Broekaert

Willem is the Managing Director of V-Bio Ventures, a life sciences venture capital fund. Before co-founding V-Bio Ventures in 2015, Willem spent over 15 years working in and growing venture capital-backed life sciences companies as an entrepreneur, consultant, and executive. He was the founder and CEO of Fugeia NV (now owned by Cargill), and Vice President R&D of CropDesign NV (now part of BASF). Before joining CropDesign NV, Willem was a professor of plant biotechnology and plant pathology at the University of Leuven, Belgium. Willem holds an M.Sc. and Ph.D. in Bioscience Engineering from the University of Leuven, Belgium, and a master’s degree in agricultural economics from IGIA/ESSEC in Paris, France.

Aphea.Bio, Coave Therapeutics, and RootWave

Name

Matias Tezanos

Willem Broekaert

Firm

Work History

22 years building tech companies. Investor in global ventures, most based in the US. A few in Latin America. A few in Europe. A few in Asia. 4 exits as CEO during a 14 year window (one at a time). The exits enabled me to start investing in innovative founders/teams/companies, which turned out to be an activity I really enjoy doing.

Willem is the Managing Director of V-Bio Ventures, a life sciences venture capital fund. Before co-founding V-Bio Ventures in 2015, Willem spent over 15 years working in and growing venture capital-backed life sciences companies as an entrepreneur, consultant, and executive. He was the founder and CEO of Fugeia NV (now owned by Cargill), and Vice President R&D of CropDesign NV (now part of BASF). Before joining CropDesign NV, Willem was a professor of plant biotechnology and plant pathology at the University of Leuven, Belgium. Willem holds an M.Sc. and Ph.D. in Bioscience Engineering from the University of Leuven, Belgium, and a master’s degree in agricultural economics from IGIA/ESSEC in Paris, France.

Other Seats

Advano, Diamond Foundry, Getaround, and Kaptyn

Aphea.Bio, Coave Therapeutics, and RootWave

Orionis Biosciences Management Team

1 Team Member

Orionis Biosciences has 1 executive. Orionis Biosciences's current Founder, Chief Executive Officer, President is Nikolai Kley.

Name

Work History

Title

Status

Nikolai Kley

FORMA Therapeutics, GPC Biotech, Princeton University, Massachusetts General Hospital, and Max Planck Institute

Founder, Chief Executive Officer, President

Current

Name

Nikolai Kley

Work History

FORMA Therapeutics, GPC Biotech, Princeton University, Massachusetts General Hospital, and Max Planck Institute

Title

Founder, Chief Executive Officer, President

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.